| 11827711 |
Antibodies binding to NKG2D |
Stefan Dengl, Ralf Hosse, Inja Waldhauer, Christian Klein, Pablo Umana |
2023-11-28 |
| 11820816 |
Anti-VEGF antibodies and methods of use |
Stefan Dengl, Sebastian Fenn, Joerg Moelleken, Francesca ROS, Esther Koenigsberger |
2023-11-21 |
| 11787873 |
Bispecific HER2 antibodies and methods of use |
Rebecca CROASDALE-WOOD, Lydia Jasmin Hanisch, Thomas Hofer, Ralf Hosse, Christian Klein +7 more |
2023-10-17 |
| 11739142 |
Bispecific anti-CCL2 antibodies |
Jens Fischer, Anton Jochner, Gregor Jordan, Hubert Kettenberger, Joerg Moelleken +11 more |
2023-08-29 |
| 11680110 |
Three-dimensional structure-based humanization method |
Johannes Auer, Stefan Klostermann, Wolfgang Schaefer |
2023-06-20 |
| 11673968 |
Anti-BRDU antibodies and methods of use |
Ulrich Brinkmann, Johannes Auer, Wilma Lau |
2023-06-13 |
| 11608376 |
Tumor-targeted agonistic CD28 antigen binding molecules |
Thomas Hofer, Ralf Hosse, Christian Klein, Ekkehard Moessner, Johannes SAM +5 more |
2023-03-21 |
| 11584793 |
Anti-transferrin receptor antibodies with tailored affinity |
Stefan Dengl, Ulrich Goepfert, Jens Niewoehner, Tilman Schlothauer |
2023-02-21 |
| 11572404 |
Humanized anti-Tau(pS422) antibodies and methods of use |
Stefan Dengl, Thomas Emrich, Ulrich Goepfert, Fiona Grueninger, Adrian Hugenmatter +9 more |
2023-02-07 |
